Terveystalo Oy Ord (TTALF) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

forecasted in our plan was in occupational health, and that's specifically in the buying behavior, lower buying activities in our existing customers than we saw during Q1. That's partly seasonal, partly it's due to the pressure on different companies with their own finances, and we are taking action on that front. that's going to be high focus going forward after summer break during H2. But all in all, looking at the revenue picture and market opportunities, there's, as I said, ample opportunities to grow. This will be further supported by a fairly active M&A market, where we are also taking action. Kela65, it's an exciting new model. We have, of course, as a backbone public system in Finland, we have mature occupational health care and insurance market. But to make sure that there's access to services for all of the segments, new innovation is needed, and Kela65 is a positive model. a positive push to improve access to care for people who typically fall out from workforce and fall out from occupational health care services. Under this scheme, citizens over 65 can use private services with the same fee as they would be using public services. And the expected volumes in this trial will be material. And Terve Stalo's position to capture its fair share of the market is very good. Looking at the consumer preference in this segment, Terve Stalo is number one choice. And we are all in this pilot. And it's going to support H2 revenue. We acknowledge that there was a softness in occupational health care during Q2. We are taking action. We are investing heavily in customer-facing solutions as we speak. In technology front, we hope that we will be able to disclose some exciting news in Q2. in the area during the coming weeks, we will design our services to cater for changed ma...